Chi Wei Lu
About Chi Wei Lu
Chi Wei Lu is an Associate Director Clinical Research Scientist with extensive experience in immuno-oncology, pain management, and women's health. He holds a Ph.D. in Biochemistry from Rutgers University and has completed postdoctoral studies at Harvard Medical School, focusing on stem cell biology and leukemia.
Work at Insmed
Chi Wei Lu serves as the Associate Director Clinical Research Scientist at Insmed Incorporated. In this role, he has been involved in overseeing clinical research initiatives since 2020. His responsibilities include managing clinical development operations, clinical operations, and pipeline development. This position allows him to leverage his extensive background in clinical research and scientific expertise to contribute to the company's objectives.
Education and Expertise
Chi Wei Lu has a strong educational background in the life sciences. He earned his Doctor of Philosophy (Ph.D.) in Biochemistry from Rutgers University, where he studied from 1996 to 2003. He furthered his education at Harvard Medical School, focusing on stem cell biology and leukemia during his postdoctoral studies from 2013 to 2017. His expertise encompasses immuno-oncology, pain management, and women's health, supported by his academic and professional experiences.
Background in Clinical Research
Before joining Insmed, Chi Wei Lu held several significant positions in clinical research. He worked as the Director of Research at the Women's Health Institute at Rutgers Robert Wood Johnson Medical School from 2014 to 2018. He also served as a Resident Scientist at the Child Health Institute of New Jersey from 2011 to 2018. His experience includes a role as Director of Clinical Research Science at Sorrento Therapeutics, Inc. from 2018 to 2020.
Postdoctoral Research Experience
Chi Wei Lu has completed multiple postdoctoral research programs that have enriched his scientific knowledge. He conducted research at the Whitehead Institute for Biomedical Research from 2012 to 2013, focusing on leukemia, oncology, and cell migration. Additionally, he pursued postdoctoral studies at Harvard Medical School from 2013 to 2017, concentrating on stem cell biology and leukemia, further enhancing his expertise in these critical areas.
Certifications and Professional Development
Chi Wei Lu has pursued professional development through various certifications. He studied at SOCRA and achieved the Clinical Research Associate Certification (CCRP). This certification reflects his commitment to maintaining high standards in clinical research and enhances his qualifications in the field.